Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.
- Published In:
- Inflammation, 34(3), 198-202 (2011)
- Authors:
- Wang, Xinying, Li, Weiqin, Niu, Chenglin, Pan, Liya, Li, Ning, Li, Jieshou
- Database ID:
- RPEP-01883
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01883APA
Wang, Xinying; Li, Weiqin; Niu, Chenglin; Pan, Liya; Li, Ning; Li, Jieshou. (2011). Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.. Inflammation, 34(3), 198-202. https://doi.org/10.1007/s10753-010-9224-1
MLA
Wang, Xinying, et al. "Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.." Inflammation, 2011. https://doi.org/10.1007/s10753-010-9224-1
RethinkPeptides
RethinkPeptides Research Database. "Thymosin alpha 1 is associated with improved cellular immuni..." RPEP-01883. Retrieved from https://rethinkpeptides.com/research/wang-2011-thymosin-alpha-1-is
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.